Linking Neuroinflammation and Neurodegeneration

Cisbio invites you to join them for an educational webinar. 

The Scientist Creative Services Team
May 20, 2020

FREE Webinar

Thursday, June 4, 2020
2:30 - 4:00 PM, Eastern Standard Time

Register/Watch On-Demand Now

Neuroinflammation plays a prominent role in the onset and progression of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Exactly how neuroinflammation leads to neurodegeneration is unclear, but neuroinflammation is associated with altered CNS homeostasis, protein misfolding, and neuronal degradation. This webinar, brought to you by The Scientist and sponsored by PerkinElmer | Cisbio, will highlight the complex interactions between neuroinflammation and neurodegeneration, as well as how scientists are securing a better understanding of this relationship.

Topics to be covered

  • Innate immunity in neurodegenerative disease
  • Incorporating functional assays to understand immune-glial interactions in both acute injury and chronic disease

Register/Watch On-Demand Now

Meet the Speakers:

Michael Heneka, MD, PhD
Chair, Dept. of Neurodegenerative Disease and Geriatric Psychiatry/Neurology
German Center for Neurodegenerative Disease (DZNE)
University of Bonn Medical Center

Shane Liddelow, PhD
Neuroscience Institute
Assistant Professor, Department of Neuroscience and Physiology
Assistant Professor, Department of Ophthalmology
New York University Langone Medical Center

July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning


Sponsored Product Updates

New England Biolabs' SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes
The research use only kit can be used as a simple alternative to RT-qPCR for SARS-CoV-2 analysis
LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers
The SARS-CoV-2 coronavirus and subsequent COVID-19 pandemic places the subject of viruses and virology in the research spotlight for good reason.
Defeating COVID-19: The Science Behind a New ELISA for COVID-19 Seroconversion Detection
The recent and rapid spread of the novel coronavirus, SARS-CoV-2, has necessitated the development of new assays that are capable of detecting the presence of this virus in patient samples or evidence of recent infection. One strategy being developed are assays to detect the presence of anti-SARS-CoV-2 antibodies in patient sera.
Imaging Multicolor Western Blots
Introducing The FluorChem R Imaging System